Cite
HARVARD Citation
Kato, T. et al. (n.d.). Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3. Cancer science. 106 (9), pp. 1202-1211. [Online].